ArticleAAPS PharmSciTech2026
Single-Step Solvent Evaporation Via Spray-Drying for the Production of Ph-Sensitive Polymeric Nanospheres for Dermatological Applications.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymeric nanospheres are promising drug delivery systems capable of controlling the release of active molecules. However, their inherent colloidal instability necessitates the use of drying techniques to enhance physicochemical stability and microbial resistance. However, conventional multi-step production processes hinder industrial-scale-up due to increased complexity and longer processing times. This work aimed to develop a single-step spray-drying process to obtain Eudragit® L100 nanospheres in powder form, thereby eliminating the need for traditional solvent evaporation, and to investigate the effects of incorporating these nanospheres into hydroxyethyl cellulose gels for dermatological applications. Eudragit® L100 was selected for its controlled release at approximately pH 6.00, facilitating delivery to specific areas, particularly on barrier-disrupted skin. Nanospheres were produced via nanoprecipitation followed by direct spray-drying to reduce production time. The nanosuspension and redispersed dried formulations were characterized by particle size, polydispersity index, morphology, and zeta potential. Before drying, the nanospheres had an average size (Z-average) of 114 nm and a polydispersity index (PdI) of 0.19 and successfully preserved their properties after a single drying step (Z-average = 140 nm and PdI = 0.2). Zeta potential was altered (p < 0.05) but remained high (-23 to -17 mV), indicating electrostatic stabilization. Gel formulations exhibited dose-dependent pseudoplastic behavior, with consistency decreasing proportionally to nanosphere concentration. Finally, moderate to strong correlations were found between rheology and textural analysis. This single-step solvent removal methodology represents a significant manufacturing advancement, offering reduced processing time and costs. The pH-responsive nanospheres showed excellent redispersibility and gel compatibility, establishing their potential as carriers for dermatological systems.
Indexed as
Identifiers
42778814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.